Skip to main content

Opioids..decoupling pain from itching...here we go


Animal researchers are making remarkable progress in understanding the complex neurophysiologic interrelationships between the sensations of itch and pain. Recent discoveries in this area have the potential to transform the clinical management of human pain, especially for patients who experience intense itching in association with the in-hospital administration of epidural morphine. Among the most promising of these discoveries, in late 2011, using a mouse model, a group from the Washington University School of Medicine was successful in uncoupling the desired analgesic effect of morphine from the unwanted effect of itching.1
The strategy employed by the researchers was a sequential series of molecular, cellular, biochemical, and behavioral experiments that culminated in blocking one variant of the μ-opioid receptor, MOR1D.The group’s strategy built on earlier findings that showed MOR1 is the predominant receptor mediating the analgesic effects of morphine in the spinal cord, and that one particular isoform, MOR1D (differing from MOR1 by only 7 amino acids), induces itching by activating gastrin-releasing peptide receptor (GRPR).1 GRPR is co-expressed with MOR1D in spinal cord neurons and importantly, transmits the sensation of itch but not pain.1,2 Prior to the discovery that GRPR-expressing neurons represent a “labeled line” for the transmission of itch signals in the spinal cord, suppression of pain signaling was thought to be necessary for the perception of itch (a concept termed the “selectivity” theory).1,3 The finding of an opioid receptor variant, MOR1D, that does not alleviate pain, together with the discovery of an itch-specific receptor, GRPR, represents a noteworthy scientific breakthrough. Similar investigative approaches are now being applied to decoupling analgesia from the other dose-limiting side effects of opioids, namely nausea, constipation, and respiratory depression.4,5 In addition, novel therapies for debilitating itching may also develop out of this important research aimed at improving the tolerability of opioids.2


1. Liu X, Liu Z, Sun Y, et al. Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids. Cell 2011 October 14;147(2):447-458.  [PMID: 22000021]

2. Cevikbas F, Steinhoff M, Ikoma A. Role of spinal neurotransmitter receptors in itch: new insights into therapies and drug development. CNS Neurosci Ther 2011 December;17(6):742-749.  [PMID: 20950328]

3. Miyamoto T, Patapoutian A. Why Does Morphine Make You Itch? [editorial]. Cell 2011 October 14;147(2):261-262.  [PMID: 22000005]

4. Dryden J. Researchers block morphine’s itchy side effect. October 13, 2011. Newsroom. Washington University in St. Louis. Copyright 2010.https://news.wustl.edu/news/Pages/22805.aspx.

5. Ross SE. Pain and itch: insights into the neural circuits of aversive somatosensation in health and disease. Current Opinion in Neurobiology 2011 December;21(6):880-887.  [PMID: 22054924]

Comments

Popular posts from this blog

Driving Pressure in ARDS: A new concept!

Driving Pressure and Survival in the Acute Respiratory Distress Syndrome Marcelo B.P. Amato, M.D., Maureen O. Meade, M.D., Arthur S. Slutsky, M.D., Laurent Brochard, M.D., Eduardo L.V. Costa, M.D., David A. Schoenfeld, Ph.D., Thomas E. Stewart, M.D., Matthias Briel, M.D., Daniel Talmor, M.D., M.P.H., Alain Mercat, M.D., Jean-Christophe M. Richard, M.D., Carlos R.R. Carvalho, M.D., and Roy G. Brower, M.D. N Engl J Med 2015; 372:747-755 February 19, 2015 DOI: 10.1056/NEJMsa1410639 BACKGROUND Mechanical-ventilation strategies that use lower end-inspiratory (plateau) airway pressures, lower tidal volumes (V T ), and higher positive end-expiratory pressures (PEEPs) can improve survival in patients with the acute respiratory distress syndrome (ARDS), but the relative importance of each of these components is uncertain. Because respiratory-system compliance (C RS ) is strongly related to the volume of aerated remaining functional lung during disease (termed functional lung size)...

Anaphylaxis updates part 2- Empty Ventricle Syndrome

Patients with anaphylaxis should not suddenly sit, stand, or be placed in the upright position. Instead, they should be placed on the back with their lower extremities elevated or, if they are experiencing respiratory distress or vomiting, they should be placed in a position of comfort with their lower extremities elevated. This accomplishes 2 therapeutic goals: 1) preservation of fluid in the circulation (the central vascular compartment), an important step in managing distributive shock; and 2) prevention of the empty vena cava/empty ventricle syndrome, which can occur within seconds when patients with anaphylaxis suddenly assume or are placed in an upright position. Patients with this syndrome are at high risk for sudden death. They are unlikely to respond to epinephrine regardless of route of administration, because it does not reach the heart and therefore cannot be circulated throughout the body

Epidural catheter tests...not only the test dose

Siphon test The catheter is held upright and a fluid level sought. If the catheter is then elevated, the fluid level should fall (see inset) as the fluid siphons in to the epidural space, which is usually under negative pressure compared with atmospheric. If the fluid column continues to rise, this may suggest subarachnoid placement. The siphon test can be reassuring, but is not mandatory. Aspiration  This should be considered mandatory. The Luer connector is attached to the catheter and a syringe is used to apply negative pressure. Free and continued aspiration of clear fluid can indicate subarachnoid placement of the catheter. However, if saline has been used for loss of resistance, it is not unusual for a small amount of this to be aspirated. If there is doubt, the aspirated fluid can be tested for glucose (cerebrospinal fluid will generally test positive) or mixed with thiopentone (cerebrospinal fluid forms a precipitate). If blood is freely and continuously aspirated, this sug...